Mydicar is under clinical development by Sardocor and currently in Phase II for Systolic Heart Failure. According to GlobalData, Phase II drugs for Systolic Heart Failure have a 67% phase transition ...
Sci & Tech and currently in Phase III for Systolic Heart Failure. According to GlobalData, Phase III drugs for Systolic Heart Failure have a 63% phase transition success rate (PTSR) indication ...
"We found that for most people with Type 2 diabetes, lowering systolic blood pressure to less than 120 mm Hg reduced the risk of major cardiovascular events," said lead study author Guang Ning, M ...
Arterial hypertension in the elderly is a major health economy burden. Systolic hypertension is an expression of increased arterial stiffness, especially of the large arteries. Adequate ...
In this paper, we first review in detail the basic building blocks of reconfigurable devices, essentially, the field-programmable gate arrays, then we describes a high-speed, reconfigurable Systolic ...
Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in ...
Systolic blood pressure of less than 120 mm Hg can stop people with type 2 diabetes from going on to develop cardiovascular disease, a new study has shown. People who lower their high systolic blood ...